Back
Profire Energy 10K Form
Buy
70
PFIE
Profire Energy
Last Price:
$2.54
Seasonality Move:
22.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | PFIE/Profire Energy Quarterly |
2023-11-08 | 10Q | PFIE/Profire Energy Quarterly |
2023-08-09 | 10Q | PFIE/Profire Energy Quarterly |
2023-05-09 | 10Q | PFIE/Profire Energy Quarterly |
2022-11-02 | 10Q | PFIE/Profire Energy Quarterly |
2022-08-04 | 10Q | PFIE/Profire Energy Quarterly |
Receive PFIE News And Ratings
See the #1 stock for the next 7 days that we like better than PFIE
PFIE Financial Statistics
Sales & Book Value
Annual Sales: | $58.2M |
---|---|
Cash Flow: | $-340.9K |
Price / Cash Flow: | 49.21 |
Annual Sales: | $1.33 |
Price / Book: | 1.9 |
Profitability
EPS (TTM): | 0.18000 |
---|---|
Net Income (TTM): | $9M |
Gross Margin: | $30.5M |
Return on Equity: | 15.36% |
Return on Assets: | 13.59% |
Profire Energy Earnings Forecast
Key Profire Energy Financial Ratios
-
The Gross Profit Margin over the past 19 years for PFIE is 52.45%.
-
The Selling, General & Administrative Expenses for PFIE have been equal to 29.52% of Gross Profit Margin.
-
The Research & Development expenses have been 1.58% of Revenue.
-
The Interest Expense is 0.09% of Operating Income.
-
The Net Earning history of PFIE is 18.51% of Total Revenues.
-
Per Share Earnings over the last 19 years have been positive in 11 years.
Profire Energy Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Energy Equipment & Services |
Sector: | Energy |
Current Symbol: | PFIE |
CUSIP: | 74316X |
Website: | profireenergy.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 6.24 |
Quick Ratio: | 3.54 |
Price-to-Earnings
Trailing P/E Ratio: | 11.55 |
---|---|
Forward P/E Ratio: | 15.39 |
PFIE Technical Analysis vs Fundamental Analysis
Buy
70
Profire Energy (PFIE)
is a Buy
Is Profire Energy a Buy or a Sell?
-
Profire Energy stock is rated a BuyThe current Profire Energy [PFIE] share price is $2.54. The Score for PFIE is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.